Shanta Kumar|Pharmaceutical Industry|Manmohan Singh|Investments|Intellectual Property|Indian Patents Act|Indian Market|Foreign Direct Investment|FDI|Economy|Anand Sharma
-
Panel for FDI ban in pharma companies
NEW DELHI: A Parliamentary panel has recommended a ban on…
Read more